Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM181 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MARCH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIF1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ULK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928589 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2V2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NARF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIPAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EML5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB22A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHNAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FARP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on